Needle service provider trends for image and performance enhancing drugs in Queensland, Australia 2016–2023
Bibliographic Data
| ID | 21605321 |
|---|---|
| Authors | Mostafa Mardani (0000-0001-9046-237X, NHMRC, Centre of Research Excellence on Achieving the Tobacco Endgame, School of Public Health, The University of Queensland), Cheneal Puljevic (0000-0002-3658-9772, The University of Queensland), Mason Levey (The University of Queensland), Geoffrey Davey (Queensland Injectors Health Network), Milena Arsenijevic (The University of Queensland), Jason Ferris (0000-0001-7474-0173, The University of Queensland), Timothy Piatkowski (0000-0002-6177-0266, Queensland Injectors Voice for Advocacy and Action, corresponding author) |
| Year | 2026 |
| Pages | 1-10 |
| Publication date | 2026-01-29 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Drugs Education Prevention and Policy (JOURNAL) |
| Journal identifiers | ISSN: 0968-7637 • E-ISSN: 1465-3370 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/09687637.2026.2619695 |
| OpenAlex | W7126246229 |
| Language | EN |
| References cited | 59 |
Background Image and performance-enhancing drug (IPED) use is an emerging health concern in Australia, particularly within needle and syringe programs (NSPs). This study examined trends in IPED equipment access, demographic shifts, and metropolitan–regional disparities in Queensland (2016–2023).Methods A retrospective observational analysis used data from Queensland NSPs and the Queensland Injectors Health Network (QuIHN) (2016–2023). Statistical tests (paired t-tests, ANOVA, Chi-square) assessed changes in demographics and regional access patterns.Results Access to IPED injection equipment via QNSP services declined from 12.4% (2016–2019) to 8.7% (2021–2023, p < 0.01), with requests nearly halving in 2020 during the pandemic. Access among clients aged 16–24 years dropped 4.2% post-COVID (p < 0.05). QuIHN services increased from 9.5% to 17.9% (p < 0.01). Regional sites recovered faster than metropolitan ones, increasing provision nearly twice as quickly (1.56% vs. 0.94% per month). Younger people (18–24 years) showed rising initiation rates over the study period.Conclusion IPED equipment provision increased prior to 2020 and stabilized post-pandemic at elevated levels. Rising service provision among younger clients highlights the need for targeted education and accessible harm reduction services, while regional differences emphasize the importance of alternative service delivery models, ongoing monitoring, and coordinated stakeholder engagement
Health services · Qualitative research · Service provider · Economic and Financial Impacts of Cancer · Medication Adherence and Compliance · Pain Management and Opioid Use
The global epidemiology of anabolic-androgenic steroid use
Preventing, producing, or reducing harm? Fitness doping risk and enabling environments
“I would never go to the doctor and speak about steroids”
‘Sustaining masculinity’
‘The general concept is a safer use approach’
Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs
The Impact of the Covid-19 Pandemic on Male Strength Athletes Who Use Non-prescribed Anabolic-Androgenic Steroids
The peer workers, they get it” – how lived experience expertise strengthens therapeutic alliances and alcohol and other drug treatment-seeking in the hospital setting
I go back to it every f**king time”
Testing the boundaries
Performance and image enhancing drug injectors’ access to needle syringe programs
Exploring the social lives of image and performance enhancing drugs
Experiences of peer work in drug use service settings
The pharmaceuticalisation of ‘healthy’ ageing
The risk environment of anabolic–androgenic steroid users in the UK
Trends in Pieds use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015
Systems mapping to understand complexity in the association between image and performance enhancing drugs (Ipeds) and harm
Big business
Human enhancement drugs
Maintaining the healthy body
Understanding muscularity, physique anxiety, and the experience of body image enhancement among men and women
Australia's Adonis
Looking Beyond the Provision of Injecting Equipment to People Who Use Anabolic Androgenic Steroids
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (Iped) Users in a Remote English Region
Men's Performance and Image-Enhancing Drug Use as Self-Transformation
Is another relationship possible? Connoisseurship and the doctor-patient relationship for men who consume performance and image-enhancing drugs
The ethics of enhancement among image and performance enhancing drug coaches
Masculine enhancement as health or pathology
A 'messenger of sex'? Making testosterone matter in motivations for anabolic-androgenic steroid injecting
You Could Try This Compound, but it Might Send You nuts
| Citation velocity | historical |
|---|---|
| Highly cited | No |